Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06507735 · ClinicalTrials.gov registry record · NA
The Effects of Mannose Supplementation on Glycosylation and Protein Levels in Human Sera
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT06507735 is a NA study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 6 participants.
The verdict
NCT06507735, a NA study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of our study is to investigate the effects of supplemental mannose on sera of humans who are healthy. We will perform proteomics studies to elucidate changes to glycan structure and protein level changes. We hypothesize that we may find that mannose supplies more properly glycosylated protein substrate and helps expedite protein synthesis, that excess mannose leads to alternative glycan structures which confer improved stability, or that there are new sites that become glycosylated after mannose supplementation.
Interventions
- DIETARY_SUPPLEMENT Mannose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2024-10-29 |
| Est. Completion | 2024-11-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06507735
The ClinicalTrials.gov registry entry for NCT06507735 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mannose is the first listed.
NCT06507735 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06507735 about?
NCT06507735 is a clinical study titled "The Effects of Mannose Supplementation on Glycosylation and Protein Levels in Human Sera". The purpose of our study is to investigate the effects of supplemental mannose on sera of humans who are healthy. We will perform proteomics studies to elucidate changes to glycan structure and protein level changes. We hypothesize that we may find that mannose supplies more properly glycosylated pr...
What is the current status of trial NCT06507735?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2024-10-29. Estimated completion is 2024-11-06.
What interventions are being tested in trial NCT06507735?
The interventions under investigation include: Mannose (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06507735?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.